COMMUNIQUÉS West-GlobeNewswire

Amarin to Report Second Quarter 2018 Results and Host Conference Call on August 1, 2018

24/07/2018 - 11:00

BEDMINSTER, N.J. and DUBLIN, Ireland, July 24, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve [...]

Transactions in relation to share buyback program

24/07/2018 - 10:56

Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 2, 2018, in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]

ViroGates Releases Second Quarter 2018 Financial Results

24/07/2018 - 09:41

Company announcement no. 4-2018 Birkerød, 24 July 2018 ViroGates Releases Second Quarter 2018 Financial Results ViroGates A/S (Nasdaq First North Denmark: VIRO), who delivers blood test systems for the Emergency [...]

Sensorion Initiates Safety Study of Seliforant Versus Meclizine In Evoked Vestibular Imbalance

24/07/2018 - 07:30

Safety and pharmacodynamic effects of seliforant compared to meclizine MONTPELLIER, France, July 24, 2018 (GLOBE NEWSWIRE) -- Sensorion (FR0012596468 – ALSEN), a biotech company specializing in the treatment of inner [...]

Idorsia announces financial results for the first half 2018

24/07/2018 - 07:01

Allschwil, Switzerland - July 24, 2018 Idorsia Ltd (SIX: IDIA) today announced its financial results for the first half of 2018. Jean-Paul Clozel, MD and Chief Executive Officer, commented: "We have made significant [...]

AC Immune Announces Closing of First Subscription Rights Offering and Primary Offering as well as Full Exercise of Option to Purchase Additional Shares

24/07/2018 - 02:31

Lausanne, Switzerland, July 24, 2018 - AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical-stage biopharmaceutical company focused on neurodegenerative diseases, today announced the closing of its previously announced [...]

UPDATE - Lexicon Pharmaceuticals to Host Second Quarter 2018 Financial Results Conference Call and Webcast on July 30, 2018

23/07/2018 - 22:46

THE WOODLANDS, Texas, July 23, 2018 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq:LXRX), will release its second quarter 2018 financial results on Monday, July 30, 2018 before market opens. Management will [...]

Ascendis Pharma A/S Announces Poster Presentation on TransCon Technology at the Controlled Release Society Annual Meeting

23/07/2018 - 22:44

COPENHAGEN, Denmark, July 23, 2018 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs, today [...]

Radius Health to Announce Second Quarter 2018 Financial Results, Host Conference Call and Live Webcast on August 7, 2018

23/07/2018 - 22:44

WALTHAM, Mass., July 23, 2018 (GLOBE NEWSWIRE) -- Radius Health (Nasdaq:RDUS) announced today that it will release its second quarter financial results on Tuesday, August 7, 2018. The Company will host a conference call [...]

Teladoc Announces Proposed Sale of Shares of Common Stock

23/07/2018 - 22:40

PURCHASE, NY, July 23, 2018 (GLOBE NEWSWIRE) -- Teladoc, Inc. (NYSE:TDOC) (“Teladoc”) today announced a proposed sale of shares of its common stock, which includes 5,000,000 shares offered by Teladoc and 263,740 shares [...]

Reata Pharmaceuticals, Inc. Announces Proposed Public Offering of Class A Common Stock

23/07/2018 - 22:39

IRVING, Texas, July 23, 2018 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq:RETA) (“Reata” or the “Company”), a clinical-stage biopharmaceutical company, today announced its intention to offer and sell 3,000, [...]

Vericel to Report Second-Quarter 2018 Financial Results on August 6, 2018

23/07/2018 - 22:36

CAMBRIDGE, Mass., July 23, 2018 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced the following webcast and [...]

Akcea Therapeutics to Hold Second Quarter 2018 Financial Results Webcast

23/07/2018 - 22:30

Webcast scheduled for Monday, August 6th at 4:30 p.m. Eastern Time CAMBRIDGE, Mass., July 23, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (Nasdaq:AKCA), an affiliate of Ionis Pharmaceuticals, Inc., announced today [...]

Medigus Announces Closing of $10 Million Public Offering

23/07/2018 - 22:05

OMER, Israel, July 23, 2018 (GLOBE NEWSWIRE) -- Medigus Ltd. (“Medigus” or the “Company”)(NASDAQ:MDGS) (TASE:MDGS), a medical device company developing minimally invasive endosurgical tools and a leader in direct [...]

Establishment Labs Announces Closing of Initial Public Offering and Exercise in Full of Underwriters' Option to Purchase Additional Common Shares

23/07/2018 - 22:05

NEW YORK, July 23, 2018 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company focused on breast aesthetics and reconstruction technologies, today announced the closing [...]

Cara Therapeutics Announces Closing of Its Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

23/07/2018 - 22:02

STAMFORD, Conn., July 23, 2018 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a clinical-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate [...]

TiGenix: Transparency notification pursuant to Article 14 of the Law of May 2, 2007

23/07/2018 - 22:01

REGULATED INFORMATION PRESS RELEASE Transparency notification pursuant to Article 14 of the Law of May 2, 2007 Leuven (Belgium) - July 23, 2018, 22:00h CET - TiGenix NV (Euronext Brussels and Nasdaq: TIG; "TiGenix") [...]

Lexicon Pharmaceuticals to Host First Quarter 2018 Financial Results Conference Call and Webcast on July 30, 2018

23/07/2018 - 22:01

THE WOODLANDS, Texas, July 23, 2018 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq:LXRX), will release its second quarter 2018 financial results on Monday, July 30, 2018 before market opens. Management will [...]

Genesis HealthCare Expects to Release Second Quarter 2018 Results on August 7, 2018

23/07/2018 - 22:01

KENNETT SQUARE, Pa., July 23, 2018 (GLOBE NEWSWIRE) -- Genesis HealthCare (NYSE:GEN) (Genesis or the Company), one of the nation’s largest providers of post-acute care, today announced that it expects to release its [...]